Gene sequencing enabled researchers to identify the specific milk protein that triggered a patient’s eosinophilic esophagitis ...

Copay Assistance From The Assistance Fund Now Available for Eligible People Living With Eosinophilic Esophagitis ORLANDO, FLORIDA / ACCESS Newswire / April 28, 2025 / The Assistance Fund, an independe ...

Results from the dual Phase III TRIUMpH trials demonstrated the statistical superiority of tegoprazan over lansoprazole in ...

New data includes real-world analyses of VOQUEZNA-treated patients in the U.S. diagnosed with gastroesophageal reflux disease (GERD) FLORHAM PARK, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Phathom ...

Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...

Eosinophilic esophagitis (EoE) is a long-term immune system disease that causes inflammation to your esophagus, the tube that connects your mouth and stomach. Scientists think this may happen when ...

First described nearly 20 years ago, eosinophilic esophagitis (EoE) is an inflammatory disease of the esophagus characterized by eosinophilic infiltration of the esophageal epithelium. Over 50% of ...

Physicians and patient advocates are sounding the alarm after the NIH abruptly withdrew a grant renewal application for the ...

Trouble swallowing can cause anxiety, and anxiety can cause trouble swallowing. Certain techniques can help you break the ...

Sebela Pharma announces positive results from phase 3 TRIUMpH programme of tegoprazan in GERD: Braintree, Massachusetts Friday, April 25, 2025, 18:00 Hrs [IST] Braintree Laborator ...

Fexuclue, a novel potassium-competitive acid blocker (PCAB), is approved as a new treatment for adults with erosive esophagitis of all grades. Sun Pharma has obtained rights from Daewoong ...